The COX-2 inhibitors- An update

被引：7

作者：

Furberg, Curt D. ^{[1
]}

机构：

[1] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27109 USA

来源：

AMERICAN HEART JOURNAL | 2006年 / 152卷 / 02期

关键词：

D O I：

10.1016/j.ahj.2006.05.022

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：197 / 199

页数：3

共 9 条

[1] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].

Bombardier, C ;

Laine, L ;

Reicin, A ;

Shapiro, D ;

Burgos-Vargas, R ;

Davis, B ;

Day, R ;

Ferraz, MB ;

Hawkey, CJ ;

Hochberg, MC ;

Kvien, TK ;

Schnitzer, TJ ;

Weaver, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528

[2] Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis [J].

Caldwell, B ;

Aldington, S ;

Weatherall, M ;

Shirtcliffe, P ;

Beasley, R .

JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2006, 99 (03) :132-140

[3]

CANNON CP, IN PRESS AM HEART J

[4] Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial [J].

Farkouh, ME ;

Kirshner, H ;

Harrington, RA ;

Ruland, S ;

Verheugt, FW ;

Schnitzer, T ;

Burmester, GR ;

Mysler, E ;

Hochberg, MC ;

Doherty, M ;

Ehrsam, E ;

Gitton, X ;

Krammer, G ;

Mellein, B ;

Gimona, A ;

Matchaba, P ;

Hawkey, CJ ;

Chesebro, JH .

LANCET, 2004, 364 (9435) :675-684

[5] Risk of cardiovascular events and rofecoxib: cumulative meta-analysis [J].

Juni, P ;

Nartey, L ;

Reichenbach, S ;

Sterchi, R ;

Dieppe, PA ;

Egger, M .

LANCET, 2004, 364 (9450) :2021-2029

[6] Reporting of noninferiority and equivalence randomized trials - An extension of the CONSORT Statement [J].

Piaggio, G ;

Elbourne, DR ;

Altman, DG ;

Pocock, SJ ;

Evans, SJW .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (10) :1152-1160

[7] Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I study [J].

Singh, G ;

Fort, JG ;

Goldstein, JL ;

Levy, RA ;

Hanrahan, PS ;

Bello, AE ;

Andrade-Ortega, L ;

Wallemark, C ;

Agrawal, NM ;

Eisen, GM ;

Stenson, WF ;

Triadafilopoulos, G .

AMERICAN JOURNAL OF MEDICINE, 2006, 119 (03) :255-266

[8] Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic [J].

Warner, TD ;

Mitchell, JA .

FASEB JOURNAL, 2004, 18 (07) :790-804

[9]

CELEBREX LABEL BLACK

← 1 →